How much funding has Amber raised?

Amber has raised $26.0M in total funding, most recently a seed round.

Who are Amber's investors?

Amber's investors include Playground Global, Andreessen Horowitz, Hummingbird Ventures, Retinal Degeneration Fund.

Where is Amber headquartered?

Amber is headquartered in San Francisco, California, United States.

What industry is Amber in?

Amber operates in Artificial Intelligence, Healthcare, Biotech.

Amber

San Francisco, United States · Founded 2023 · $26.0M raised

Artificial Intelligence

Healthcare

Biotech

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2023
Website: amber.bio

Total Funding: $26.0M
Last Round: $26.0M SeedAug 2023
Rounds: 1

About

Amber Bio is a San Francisco biotechnology company developing an RNA-editing platform that enables programmable, multi-kilobase edits to RNA in a single step. Spun out of research from the Broad Institute and UC Berkeley, its CRISPR-mediated trans-splicing technology rewrites thousands of bases without cutting DNA, making it suited to genetic diseases with high allelic diversity where conventional gene editing falls short. The company launched in 2023 with a $26 million seed round co-led by Playground Global and Andreessen Horowitz Bio + Health.

Summary

Amber is an Artificial Intelligence company based in San Francisco, United States, founded in 2023. It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in Aug 2023. Investors include Playground Global, Andreessen Horowitz and Hummingbird Ventures.